Boston Scientific shares fell 2% after the company said the cyber attack would affect its net sales growth and adjusted earnings per share guidance for the third quarter and fiscal year 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.